The Rare Disease Specialty Testing Program is a global initiative by Sanofi that aims to provide comprehensive testing for patients with lysosomal storage disorders, including Fabry, Pompe, Gaucher, ASMD, and MPS I. The program is specifically designed for healthcare providers to enroll and request testing for their eligible patients. Through this initiative, Sanofi is committed to supporting healthcare providers in improving their patients management and making a positive impact on the lives of people affected by rare diseases worldwide.